Literature DB >> 21938016

Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.

Y-G Chen1, S-W Tsaih, D V Serreze.   

Abstract

Previous studies using gene-targeted mutant mice revealed several molecules important for the development or function of invariant natural killer T (iNKT) cells. However, these gene knockout mice represent cases that are rare in humans. Thus, it remains unclear how naturally occurring allelic variants of these genes or others regulate the numerical and functional diversity of iNKT cells in both mice and humans. Studies in humans are mostly limited to iNKT cells in peripheral blood (PB). It is not known if the relative distribution of iNKT cells between PB and other lymphoid organs is correlated or under common genetic control. To initially address these questions, we analyzed iNKT cells in the spleen, thymus and PB of 38 inbred mouse strains. Percentages of iNKT cells in these three anatomical sites varied significantly in a strain-dependent manner. The correlation between PB and spleen was moderate, and none was observed between PB and thymus. Similarly, proportions of the CD4-expressing subset of iNKT cells differed significantly among inbred strains. The percentages of CD4-positive iNKT cells displayed a strong correlation between PB and spleen, although it remained poor between PB and thymus. Genome-wide association studies across strains identified only partially overlapping loci associated with variability of iNKT cell frequencies within and between differing anatomical sites.

Entities:  

Mesh:

Year:  2011        PMID: 21938016      PMCID: PMC3291802          DOI: 10.1038/gene.2011.68

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  48 in total

1.  NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway.

Authors:  M Terabe; S Matsui; N Noben-Trauth; H Chen; C Watson; D D Donaldson; D P Carbone; W E Paul; J A Berzofsky
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

2.  Multiple immuno-regulatory defects in type-1 diabetes.

Authors:  Anjli Kukreja; Giulia Cost; John Marker; Chenhui Zhang; Zhong Sun; Karen Lin-Su; Svetlana Ten; Maureen Sanz; Mark Exley; Brian Wilson; Steven Porcelli; Noel Maclaren
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.

Authors:  S Hong; M T Wilson; I Serizawa; L Wu; N Singh; O V Naidenko; T Miura; T Haba; D C Scherer; J Wei; M Kronenberg; Y Koezuka; L Van Kaer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

4.  Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.

Authors:  S Sharif; G A Arreaza; P Zucker; Q S Mi; J Sondhi; O V Naidenko; M Kronenberg; Y Koezuka; T L Delovitch; J M Gombert; M Leite-De-Moraes; C Gouarin; R Zhu; A Hameg; T Nakayama; M Taniguchi; F Lepault; A Lehuen; J F Bach; A Herbelin
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

5.  Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.

Authors:  Y N Naumov; K S Bahjat; R Gausling; R Abraham; M A Exley; Y Koezuka; S B Balk; J L Strominger; M Clare-Salzer; S B Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

6.  Testing the NKT cell hypothesis of human IDDM pathogenesis.

Authors:  Peter T Lee; Amy Putnam; Kamel Benlagha; Luc Teyton; Peter A Gottlieb; Albert Bendelac
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  Genetic dissection of V alpha 14J alpha 18 natural T cell number and function in autoimmune-prone mice.

Authors:  Naoto Matsuki; Aleksandar K Stanic; Monica E Embers; Luc Van Kaer; Laurence Morel; Sebastian Joyce
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

Review 8.  Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.

Authors:  S Brian Wilson; Terry L Delovitch
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

9.  Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family.

Authors:  A C Chan; L Serwecinska; A Cochrane; L C Harrison; D I Godfrey; S P Berzins
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

10.  CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.

Authors:  B Wang; Y B Geng; C R Wang
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

View more
  7 in total

1.  Polymorphisms in the CD1d promoter that regulate CD1d gene expression are associated with impaired NKT cell development.

Authors:  Zachary D Borg; Patrick J Benoit; Graham W J Lilley; Idil Aktan; Alan Chant; Victoria L DeVault; Mercedes Rincon; Jonathan E Boyson
Journal:  J Immunol       Date:  2013-12-04       Impact factor: 5.422

2.  A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.

Authors:  S-W Tsaih; M Presa; S Khaja; A E Ciecko; D V Serreze; Y-G Chen
Journal:  Genes Immun       Date:  2015-02-05       Impact factor: 2.676

3.  Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo.

Authors:  Felix Scheuplein; Deanna J Lamont; Matthew E Poynter; Jonathan E Boyson; David Serreze; Lennart K A Lundblad; Robert Mashal; Robert Schaub
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

Review 4.  iNKT and MAIT Cell Alterations in Diabetes.

Authors:  Isabelle Magalhaes; Badr Kiaf; Agnès Lehuen
Journal:  Front Immunol       Date:  2015-07-02       Impact factor: 7.561

Review 5.  Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective.

Authors:  Guan Yang; Jürgen A Richt; John P Driver
Journal:  Int J Mol Sci       Date:  2017-12-27       Impact factor: 5.923

6.  Genetic control of murine invariant natural killer T cells maps to multiple type 1 diabetes regions.

Authors:  S W Tsaih; S Khaja; A E Ciecko; E MacKinney; Y G Chen
Journal:  Genes Immun       Date:  2013-05-30       Impact factor: 2.676

Review 7.  Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells.

Authors:  John P Driver; Darling Melany de Carvalho Madrid; Weihong Gu; Bianca L Artiaga; Jürgen A Richt
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.